Bill Text: IL HB2043 | 2011-2012 | 97th General Assembly | Chaptered
Bill Title: Amends the Senior Pharmaceutical Assistance Act. Provides that the Senior Pharmaceutical Assistance Review Committee shall meet at the call of the co-chairs, as deemed necessary (rather than but at least quarterly). Further provides that the Committee shall report to the General Assembly and the Governor as it deems necessary (rather than annually or as it deems necessary) regarding proposed or recommended changes to pharmaceutical assistance programs that benefit Illinois seniors and any associated costs of those changes. Effective immediately.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Passed) 2011-07-14 - Public Act . . . . . . . . . 97-0128 [HB2043 Detail]
Download: Illinois-2011-HB2043-Chaptered.html
| ||||
| Public Act 097-0128 | ||||
| ||||
| ||||
AN ACT concerning aging.
| ||||
Be it enacted by the People of the State of Illinois,
| ||||
represented in the General Assembly:
| ||||
Section 5. The Senior Pharmaceutical Assistance Act is | ||||
amended by changing Section 15 as follows:
| ||||
(320 ILCS 50/15)
| ||||
Sec. 15. Senior Pharmaceutical Assistance Review | ||||
Committee.
| ||||
(a) The Senior Pharmaceutical Assistance Review Committee | ||||
is
created. The Committee shall consist of 17 members as | ||||
follows:
| ||||
(1) Twelve members appointed as follows: 2 members of | ||||
the General
Assembly and 1 member of the general public, | ||||
appointed by the President of the
Senate; 2 members of the | ||||
General Assembly and 1 member of the general public,
| ||||
appointed by the Minority Leader of the Senate; 2 members | ||||
of the General
Assembly and 1 member of the general public, | ||||
appointed by the Speaker of the
House of Representatives; | ||||
and 2 members of the General Assembly and 1 member of
the | ||||
general public, appointed by the Minority Leader of the | ||||
House of
Representatives.
These members shall serve at the | ||||
pleasure of the appointing authority.
| ||||
(2) The Director of Aging or his or her designee.
| ||||
(3) The Director of Revenue or his or her designee.
| ||
(4) The Director of Healthcare and Family Services or | ||
his or her designee.
| ||
(5) The Secretary of Human Services or his or her | ||
designee.
| ||
(6) The Director of Public Health or his or her | ||
designee.
| ||
(b) Members appointed from the general public shall | ||
represent the
following associations, organizations, and | ||
interests: statewide
membership-based senior advocacy | ||
organizations, pharmaceutical manufacturers,
pharmacists,
| ||
dispensing pharmacies, physicians, and providers of services | ||
to senior
citizens.
No single organization may have more than | ||
one representative appointed as a
member from the general | ||
public.
| ||
(c) The President of the Senate and Speaker of the House of
| ||
Representatives shall each designate one member of the | ||
Committee to serve as
co-chairs.
| ||
(d) Committee members shall serve without compensation or
| ||
reimbursement for expenses.
| ||
(e) The Committee shall meet at the call of the co-chairs, | ||
as deemed necessary but at
least quarterly.
| ||
(f) The Committee may conduct public hearings to gather | ||
testimony
from interested parties regarding pharmaceutical | ||
assistance for Illinois
seniors, including changes to existing | ||
and proposed programs.
| ||
(f-5) The Committee may review federal legislation with | ||
regard to e-prescribing to determine what provisions, if any, | ||
would improve health care in Illinois. | ||
(f-6) The Committee may conduct public hearings to gather | ||
testimony regarding federal procedure for pandemic | ||
preparedness and response to determine whether or not the State | ||
should update its preparedness procedures and tactics. | ||
(g) The Committee may advise appropriate State agencies | ||
regarding
the establishment of proposed programs or changes to | ||
existing programs. The
State agencies shall take into | ||
consideration any recommendations made by the
Committee.
| ||
(h) The Committee shall report to the General Assembly and | ||
the
Governor annually or as it deems necessary regarding | ||
proposed or recommended
changes to pharmaceutical assistance | ||
programs that benefit Illinois seniors and
any associated costs | ||
of those changes.
| ||
(h-5) The Committee may conduct public hearings to gather | ||
testimony from interested parties regarding prescription drug | ||
abuse to determine whether the State should increase penalties | ||
against those engaged in conduct potentially harmful to | ||
Illinois residents, particularly those under age 25. In order | ||
to do this, the Committee may review guidelines from State | ||
universities addressing prescription drug abuse. | ||
(i) In the event that a prescription drug benefit is added | ||
to the federal
Medicare
program, the Committee shall make | ||
recommendations for the realignment of State-operated senior | ||
prescription drug programs so
that Illinois residents qualify | ||
for at least substantially the same level of benefits
available | ||
to them prior
to implementation of the Medicare prescription | ||
drug benefit, provided that a resident remains eligible for | ||
such a State-operated program. The Committee shall report its | ||
recommendations to the General
Assembly and
the Governor by | ||
January 1, 2005.
| ||
(Source: P.A. 95-331, eff. 8-21-07; 96-1183, eff. 7-22-10.)
| ||
Section 99. Effective date. This Act takes effect upon | ||
becoming law.
| ||
